Veljan Denison Ltd Board Approves Re-appointment of Dr. Suresh Akella as Independent Director
The Board of Directors of Veljan Denison Ltd has approved the re-appointment of Dr. Suresh Akella as a Non-Executive Independent Director for a second consecutive term. The approval was granted during a meeting held on August 3, 2026.The appointment is subject to the formal approval of the company's shareholders through a Special Resolution. The new term spans five years, commencing from September 30, 2026, and ending on September 29, 2031.
The decision was made based on a recommendation from the Nomination and Remuneration Committee. The Board determined that Dr. Akella continues to satisfy all criteria for independence as prescribed by regulatory guidelines. His continued association with Veljan Denison Ltd is viewed as beneficial due to his extensive expertise and qualifications.
Dr. Suresh Akella possesses significant experience in Manufacturing and FEM, bringing deep knowledge of technology and industry practices to the company's board. The Board noted that he holds no relationship with any other Director of the Company. Furthermore, it was confirmed that Dr. Akella is not debarred from holding a directorial position by SEBI or any other governing authority.
Key details regarding the re-appointment are summarized below:
| Particular | Details |
|---|---|
| Reason for Change | Re-appointment as Non-Executive Independent Director for a second consecutive term. |
| Board Approval Date | August 3, 2026 (Subject to shareholders' approval). |
| Term Duration | Five years. |
| Commencement Date | September 30, 2026. |
| End Date | September 29, 2031. |
VELJAN Stock Price Movement
Veljan Denison Limited shares today shed 3.32% in the post-market session, settling at ₹1698.90. The stock traded during this period with a total volume of 2,623 shares.Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.
Any views, opinions, or statements expressed, where applicable, are those of the respective analysts or experts and do not reflect the views of this website. The website has no association with such viewpoints and does not assume any responsibility for them.